,"Author: De Wolf, Frank",,,,,,,,,,,
,,,,,,,,,,,,
,"h index = 31 (Of the 91 documents considered for the h-Index, 31 have been cited at least 31 times.)",,,,,,,,,,,
,Note: The h Index considers Scopus documents published after 1995.  ,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,<2007,2007,2008,subtotal,>2008,total
Publication Year,Document Title,Authors,ISSN,Journal Title,Volume,Issue,5697,464,465,929,315,6941
2009,"A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy","Wang D., Perez-Elias M.J., Emery S., Gatell J., D'Arminio Monforte A., Torti C., Zazzi M., Lane C., Larder B., Revell A., Montaner J., Harrigan R., De Wolf F., Lange J., Wegner S., Ruiz L.",09333657,"Artificial Intelligence in Medicine",47, 1,0,0,0,0,0,0
2009,"Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy","Kesselring A.M., Reiss P., Mocroft A., Wit F.W., Sabin C.A., Lundgren J.D., Gill M.J., Gatell J.M., Rauch A., Montaner J.S., De Wolf F.",02699370,"AIDS",23, 13,0,0,0,0,0,0
2009,"Estimating the public health impact of the effect of herpes simplex virus suppressive therapy on plasma HIV-1 viral load","Baggaley R.F., Ghani A.C., Weiss H.A., Griffin J.T., Chapman R., Hollingsworth T.D., Nagot N., Delany S., Mayaud P., De Wolf F., Fraser C.",02699370,"AIDS",23, 8,0,0,0,0,0,0
2009,"Baseline lipid levels rather than the presence of reported body shape changes determine the degree of improvement in lipid levels after switching to atazanavir","Van Vonderen M.G.A., Gras L., Wit F., Brinkman K., Van Der Ende M.E., Hoepelman A.I.M., De Wolf F., Reiss P.",15284336,"HIV Clinical Trials",10, 3,0,0,0,0,0,0
2008,"Lower perceived necessity of HAART predicts lower treatment adherence and worse virological response in the ATHENA cohort","De Boer-Van Der Kolk I.M., Sprangers M.A.G., Van Der Ende M., Schreij G., De Wolf F., Nieuwkerk P.T.",15254135,"Journal of Acquired Immune Deficiency Syndromes",49, 4,0,0,0,0,0,0
2008,"Immunologic, virologic, and clinical consequences of episodes of transient viremia during suppressive combination antiretroviral therapy","Van Sighem A., Zhang S., Reiss P., Gras L., Van Der Ende M., Kroon F., Prins J., De Wolf F.",15254135,"Journal of Acquired Immune Deficiency Syndromes",48, 1,0,0,1,1,0,1
2008,"A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy","Bezemer D., Fraser C., De Wolf F., Boerlijst M.C., Van Sighem A., Hollingsworth T.D., Prins M., Geskus R.B., Gras L., Coutinho R.A.",02699370,"AIDS",22, 9,0,0,3,3,5,8
2008,"Late entry to HIV care limits the impact of anti-retroviral therapy in the Netherlands","Smit C., Hallett T.B., Lange J., Garnett G., de Wolf F.",19326203,"PLoS ONE",3, 4,0,0,1,1,1,2
2008,"Steady-state nevirapine plasma concentrations are influenced by pregnancy","Nellen J.F.J.B., Damming M., Godfried M.H., Boer K., Van Der Ende M.E., Burger D.M., De Wolf F., Wit F.W.N.M., Prins J.M.",14642662,"HIV Medicine",9, 4,0,0,0,0,1,1
2008,"Discontinuation of nevirapine because of hypersensitivity reactions in patients with prior treatment experience, compared with treatment-naive patients: The ATHENA cohort study","Wit F.W.N.M., Kesselring A.M., Gras L., Richter C., Van Der Ende M.E., Brinkman K., Lange J.M.A., De Wolf F., Reiss P.",10584838,"Clinical Infectious Diseases",46, 6,0,0,0,0,2,2
2008,"Lymphogranuloma venereum proctitis in men who have sex with men is associated with anal enema use and high-risk behavior","De Vries H.J.C., Van Der Bij A.K., Fennema J.S.A., Smit C., De Wolf F., Prins M., Coutinho R.A., Morre S.A.",01485717,"Sexually Transmitted Diseases",35, 2,0,0,3,3,7,10
2008,"Combination antiretroviral therapy failure and HIV super-infection","Bezemer D., Lukashov V.V., Van Sighem A., De Wolf F., Cornelissen M., Van Der Kuyl A.C., Jurriaans S., Van Der Hoek L., Prins M., Coutinho R.A.",02699370,"AIDS",22, 2,0,0,1,1,1,2
2007,"Variation in HIV-1 set-point viral load: Epidemiological analysis and an evolutionary hypothesis","Fraser C., Hollingsworth T.D., Chapman R., De Wolf F., Hanage W.P.",00278424,"Proceedings of the National Academy of Sciences of the United States of America",104, 44,0,0,8,8,12,20
2007,"Therapeutic drug monitoring of the HIV protease inhibitor atazanavir in clinical practice","Cleijsen R.M.M., Van de ende M.E., Kroon F.P., Lunel verduyn F., Koopmans P.P., Gras L., De wolf F., Burger D.M.",03057453,"Journal of Antimicrobial Chemotherapy",60, 4,0,0,6,6,2,8
2007,"Quality of life after starting highly active antiretroviral therapy for chronic HIV-1 infection at different CD4 cell counts [4]","Nieuwkerk P.T., Hillebrand-Haverkort M.E., Vriesendorp R., Frissen P.H.J., De Wolf F., Sprangers M.A.G.",15254135,"Journal of Acquired Immune Deficiency Syndromes",45, 5,0,0,1,1,0,1
2007,"CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greater","Gras L., De Wolf F., Kesselring A.M., Griffin J.T., Van Sighem A.I., Fraser C., Ghani A.C., Miedema F., Reiss P., Lange J.M.A.",15254135,"Journal of Acquired Immune Deficiency Syndromes",45, 2,0,1,12,13,17,30
2007,"The development of artificial neural networks to predict virological response to combination HIV therapy","Larder B., Perez-Elias M.J., Emery S., Monforte A.D'A., Torti C., Zazzi M., Lane C., Wang D., Revell A., Montaner J., Harrigan R., De Wolf F., Lange J., Wegner S., Ruiz L.",13596535,"Antiviral Therapy",12, 1,0,0,4,4,7,11
2006,"Semi-parametric accelerated failure time regression analysis with application to interval-censored HIV/AIDS data","Xue H., Lam K.F., Cowling B.J., de Wolf F.",02776715,"Statistics in Medicine",25, 22,0,0,0,0,0,0
2006,"Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use","Kwong G.P.S., Danner S.A., De Wolf F., Anderson R.M., Ghani A.C., Rode R.A., Bartley L.M., Cowling B.J., Da Silva B., Donnelly C.A., Van Sighem A.I., Cameron D.W.",02699370,"AIDS",20, 15,0,4,12,16,1,17
2006,"The genotypic inhibitory quotient and the (cumulative) number of mutations predict the response to lopinavir therapy","Hoefnagel J.G.M., Burger D.M., Van Der Lee M.J., Koopmans P.P., Schuurman R., Jurriaans S., Van Sighem A.I., Gras L., De Wolf F., Galama J.M.D.",02699370,"AIDS",20, 7,0,5,3,8,3,11
2006,"The effect on treatment comparisons of different measurement frequencies in human immunodeficiency virus observational databases","Griffin J.T., Fraser C., Gras L., De Wolf F., Ghani A.C.",00029262,"American Journal of Epidemiology",163, 7,0,2,0,2,0,2
2005,"Mortality in patients with successful initial response to highly active antiretroviral therapy is still higher than in non-HIV-infected individuals","Van Sighem A., Danner S., Ghani A.C., Gras L., Anderson R.M., De Wolf F.",15254135,"Journal of Acquired Immune Deficiency Syndromes",40, 2,3,5,7,12,3,18
2005,"Therapeutic drug monitoring of nevirapine reduces pharmacokinetic variability but does not affect toxicity or virologic success in the ATHENA study [1]","Crommentuyn K.M., Huitema A.D., Brinkman K., Van Der Ende M.E., De Wolf F., Beijnen J.H.",15254135,"Journal of Acquired Immune Deficiency Syndromes",39, 2,4,3,1,4,1,9
2005,"Nelfinavir and nevirapine side effects during pregnancy","Timmermans S., Van Der Ende M.E., Tempelman C., Godfried M.H., Nellen J., Dieleman J., Sprenger H., Schneider M.E.E., De Wolf F., Boer K.",02699370,"AIDS",19, 8,14,9,9,18,4,36
2005,"Gender difference in HIV-1 RNA viral loads","Donnelly C.A., Anderson R.M., Bartley L.M., Ghani A.C., Le Fevre A.M., Kwong G.P., Cowling B.J., van Sighem A.L., de Wolf F., Rode R.A.",14642662,"HIV Medicine",6, 3,4,2,2,4,2,10
2005,"Safety of long-term interruption of successful antiretroviral therapy: The ATHENA cohort study","Wit F.W.N.M., Blanckenberg D.H., Brinkman K., Prins J.M., Van Der Ende M.E., Schneider M.M.E., Mulder J.-W., De Wolf F., Lange J.M.A.",02699370,"AIDS",19, 3,7,4,8,12,0,19
2004,"Development and validation of a prognostic model for survival time data: Application to prognosis of HIV positive patients treated with antiretroviral therapy","May M., Gill J., Hogg R., Lederberger B., Phillips A., Salzberger B., Staszewski S., Royston P., Weller I., Alfandari S., Bastides F., Billaud E., Boibieux A., Boue F., Bricaire F., Cotte L., Cuzin L., Dabis F., Egger M., Fournier S., Gasnault J., Gaud C., Gilquin J., Grabar S., Lacoste D., Lang J.M., Laurichesse H., Leport C., Mary-Krause M., Justice A.C., Matheron S., Meyohas M.C., Michelet C., Moreau J., Pialoux G., Poizot-Martin I., Pradier C., Rabaud C., Rouveix E., Saiag P., Sterne J.A.C., Salmon-Ceron D., Soubeyrand J., Tissot-Dupont H., Haury B., Courtial-Destembert S., Bronsveld W., Leemhuis M.P., van Houte D.P.F., Pole M., ten Napel C.C.H., Costagliola D., Juttman J.R., Koopmans P.P., Telgt D.S.C., Schurink C.A.M., Hoepelman I.M., Schneider M.M.E., Jaspers C.A.J.J., Borleffs J.C.C., Bonten M.J.M., Jeurissen F.J.F., Vriesendorp R., Koger E.L.W., Kauffmann R.H., Richter C., van Leusen J., van der Berg J., Blok W.L., Goudsmit J., Back N.K.T., Jurriaans S., D'Arminio Monforte A., de Wolf F., Lange J.M.A., Osterhaus A.D.M.E., Niesters H.M.G., Schutten M., Kroes A.C.M., Claas H.C.J., Schuurman R., Boucher C.A.B., Vetter N., Clumneck N., Hermans P., Sommereijns B., Colebunders R., Machala L., Rozsypal H., Nielsen J., Lundgren J., Benfield T., Kirk O.",02776715,"Statistics in Medicine",23, 15,6,6,4,10,4,20
2004,"Virologic and immunologic response to highly active antiretroviral therapy in indigenous and nonindigenous HIV-1-infected patients in The Netherlands","Nellen J.F., Wit F.W., De Wolf F., Jurriaans S., Lange J.M., Prins J.M.",15254135,"Journal of Acquired Immune Deficiency Syndromes",36, 4,1,2,4,6,2,9
2004,"Declining trend in transmission of drug-resistant HIV-1 in Amsterdam","Bezemer D., Jurriaans S., Prins M., Van Der Hoek L., Prins J.M., De Wolf F., Berkhout B., Coutinho R., Back N.K.T.",02699370,"AIDS",18, 11,17,8,4,12,2,31
2004,"Differential CD4 T-cell response in HIV-1-infected patients using protease inhibitor-based or nevirapine-based highly active antiretroviral therapy","van Leth F., Lange J.M.A., Wit F.W.N.M., Reiss P., Schattenkerk J.K.M.E., van der Ende M.E., Schneider M.M.E., Mulder J.W., Frissen P.H.J., de Wolf F.",14642662,"HIV Medicine",5, 2,5,6,1,7,0,12
2003,"Mortality and progression to AIDS after starting highly active antiretroviral therapy","Van Sighem A.I., Van De Wiel M.A., Ghani A.C., Jambroes M., Reiss P., Gyssens I.C., Brinkman K., Lange J.M.A., De Wolf F.",02699370,"AIDS",17, 15,44,11,14,25,5,74
2002,"Antigen-driven T-cell turnover","Fraser C., Ferguson N.M., De Wolf F., Ghani A.C., Garnett G.P., Anderson R.M.",00225193,"Journal of Theoretical Biology",219, 2,4,0,1,1,0,5
2002,"A Bayesian approach to parameter estimation in HIV dynamical models","Putter H., Heisterkamp S.H., Lange J.M.A., De Wolf F.",02776715,"Statistics in Medicine",21, 15,10,2,1,3,1,14
2002,"Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: A collaborative analysis of prospective studies","Egger M., Reiss P., Lundgren J.D., Justice A.C., Staszewski S., Leport C., Hogg R.S., Sabin C.A., Gill M.J., Salzberger B., Sterne J.A.C., May M., Chene G., Phillips A.N., Ledergerber B., Dabis F., Costagliola D., D'Arminio Monforte A., De Wolf F.",01406736,"Lancet",360, 9327,321,95,95,190,62,573
2002,"Viral replication under combination antiretroviral therapy: A comparison of four different regimens","Ghani A.C., De Wolf F., Ferguson N.M., Fraser C., Donnelly C.A., Danner S., Reiss P., Lange J., Goudsmit J., Anderson R.M.",15254135,"Journal of Acquired Immune Deficiency Syndromes",30, 2,7,0,1,1,1,9
2002,"Erratum: Improved long-term suppression of HIV-1 replication with a triple-class multidrug regimen compared with standard of care antiretroviral therapy (AIDS (2002) 16 (719-725))","Van Praag R.M.E., Wit F.W.N.M., Jurriaans S., De Wolf F., Prins J.M., Lange J.M.A.",02699370,"AIDS",16, 8,0,0,0,0,0,0
2002,"Improved long-term suppression of HIV-1 replication with a triple-class multidrug regimen compared with standard of care antiretroviral therapy","Van Praag R.M.E., Wit F.W.N.M., Jurriaans S., De Wolf F., Prins J.M., Lange J.M.A.",02699370,"AIDS",16, 5,24,1,2,3,0,27
2002,"Determinants of recurrent toxicity-driven switches of highly active antiretroviral therapy. The ATHENA cohort","Dieleman J.P., Reiss P., Brinkman K., Jambroes M., Gyssens I.C., Sturkenboom M.C.J.M., Stricker B.H.Ch., Mulder W.M.C., De Wolf F., Weverling G.-J., Lange J.M.A.",02699370,"AIDS",16, 5,39,12,3,15,4,58
2001,"Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study","Nieuwkerk P.T., Meenhorst P.L., Sprenger H.G., Kauffmann R.H., Jambroes M., Chesney M.A., De Wolf F., Lange J.M.A., Sprangers M.A.G., Burger D.M., Hoetelmans R.M.W., Hugen P.W.H., Danner S.A., Van der Ende M.E., Schneider M.M.E., Schrey G.",00039926,"Archives of Internal Medicine",161, 21,49,7,8,15,1,65
2001,"Surrogate markers for disease progression in treated HIV infection","Ghani A.C., De Wolf F., Ferguson N.M., Donnelly C.A., Coutinho R., Miedema F., Goudsmit J., Anderson R.M.",15254135,"Journal of Acquired Immune Deficiency Syndromes",28, 3,9,5,2,7,0,16
2001,"The role of antigenic stimulation and cytotoxic T cell activity in regulating the long-term immunopathogenesis of HIV: Mechanisms and clinical implications","Fraser C., Ferguson N.M., De Wolf F., Anderson R.M.",09628436,"Proceedings of the Royal Society B: Biological Sciences",268, 1481,8,2,3,5,2,15
2001,"Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study","Nieuwkerk P.T., Meenhorst P.L., Sprenger H.G., Kauffmann R.H., Jambroes M., Chesney M.A., De Wolf F., Lange J.M.A., Sprangers M.A.G., Burger D.M., Hoetelmans R.M.W., Hugen P.W.H., Danner S.A., Van Der Ende M.E., Schneider M.M.E., Schrey G.",00039926,"Archives of Internal Medicine",161, 16,76,1,3,4,5,85
2001,"Treatment of HIV-I infection in the Netherlands: Virological and immunological response to antiretroviral therapy | Behandeling van HIV-I in Nederland: Virologische en immunologische respons op antiretrovirale therapie","Jambroes M., Schuurman R., Mulder J.W., Kroes A.C.M., Lange J.M.A., De Wolf F., Weverling G.J., Reiss P., Danner S.A., Jurriaans S., Ten Veen J.H., Van Der Ende M.E., Schutten M., Schneider M.M.E.",00282162,"Nederlands Tijdschrift voor Geneeskunde",145, 33,4,0,0,0,0,4
2001,"OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion","Van Praag R.M.E., De Wolf F., Fox C.H., Goudsmit J., Miedema F., Lange J.M.A., Prins J.M., Roos M.T.L., Schellekens P.Th.A., Ten Berge I.J.M., Yong S.-L., Schuitemaker H., Eerenberg A.J.M., Jurriaans S.",02719142,"Journal of Clinical Immunology",21, 3,26,3,5,8,5,39
2001,"Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: A randomized controlled trial","Foudraine N.A., Portegies P., De Wolf F., Lange J.M.A., Jurriaans S., Weverling G.J., Burger D.M., Hoetelmans R.M.W., Roos M.T.L., Maas J., Miedema F., Reiss P.",13596535,"Antiviral Therapy",6, 1,5,0,0,0,0,5
2000,"Slower decline of plasma HIV-1 RNA following highly suppressive antiretroviral therapy in primary compared with chronic infection","Putter H., Goudsmit J., Lange J.M.A., De Wolf F., Prins J.M., Jurriaans S., Roos M., Ferguson N.M., Van Praag R., Van der Hoek L., Schuitemaker H., Anderson R.M.",02699370,"AIDS",14, 18,10,0,1,1,0,11
2000,"Evaluation of a second-generation nucleic acid sequence-based amplification assay for quantification of HIV type 1 RNA and the use of ultrasensitive protocol adaptations","Notermans D.W., Danner S.A., Goudsmit J., Jurriaans S., De Wolf F., Oudshoorn P., Cuijpers H.T., Pirillo M., Tiller F.W., McClernon D.R., Prins J.M., Lange J.M.A.",08892229,"AIDS Research and Human Retroviruses",16, 15,9,0,0,0,0,9
2000,"Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine","Gisolf E.H., Enting R.H., Jurriaans S., De Wolf F., Van Der Ende M.E., Hoetelmans R.M.W., Portegies P., Danner S.A.",02699370,"AIDS",14, 11,33,2,2,4,3,40
2000,"Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs","Fraser C., Ferguson N.M., Ghani A.C., Prins J.M., Lange J.M.A., Goudsmit J., Anderson R.M., De Wolf F.",02699370,"AIDS",14, 6,34,1,5,6,1,41
2000,"The effect of treatment intensification in HIV-infection: A study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine","Gisolf E.H., Danner S.A., Jurriaans S., Pelgrom J., Van Wanzeele F., Van der Ende M.E., Brinkman K., Borst M.-J., De Wolf F., Japour A.J.",02699370,"AIDS",14, 4,39,1,0,1,0,40
2000,"Subtype-specific sequence variation of the HIV type 1 long terminal repeat and primer-binding site","De Baar M.P., De Ronde A., Berkhout B., Cornelissen M., Van Der Horn K.H.M., Van Der Schoot A.M., De Wolf F., Lukashov V.V., Goudsmit J.",08892229,"AIDS Research and Human Retroviruses",16, 5,19,2,1,3,0,22
1999,"Ongoing HIV dissemination during HAART","Grossman Z., Lange J.M.A., Goudsmit J., Dimitrov D.S., Paul W.E., Polis M., Feinberg M.B., Grossman Z., Levi I., Jankelevich S., Yarchoan R., Boon J., De Wolf F.",10788956,"Nature Medicine",5, 10,70,5,4,9,3,82
1999,"Maternal viral load and vertical transmission of HIV-1 an important factor but not the only one","Bailey A., Newell M.-L., Peckham C., De Rossi A., Ehrnst A., Grosch-Worner I., Coll O., De Wolf F.",02699370,"AIDS",13, 11,80,8,10,18,6,104
1999,"Design and evaluation of a human immunodeficiency virus type 1 RNA assay using nucleic acid sequence-based amplification technology able to quantify both group M and O viruses by using the long terminal repeat as target","De Baar M.P., Van Der Schoot A.M., Goudsmit J., Jacobs F., Ehren R., Van Der Horn K.H.M., Oudshoorn P., De Wolf F., De Ronde A.",00951137,"Journal of Clinical Microbiology",37, 6,29,1,1,2,0,31
1999,"Outcome and predictors of failure of highly active antiretroviral therapy: One-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons","Wit F.W.N.M., Weeda M., De Wolf F., Reiss P., Danner S.A., Lange J.M.A., Van Leeuwen R., Weverling G.J., Jurriaans S., Nauta K., Steingrover R., Schuijtemaker J., Eyssen X., Fortuin D.",00221899,"Journal of Infectious Diseases",179, 4,133,6,3,9,0,142
1999,"Insertion of two animo acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogs","De Jong J.J., Jurriaans S., Goudsmit J., Lukashov V.V., Hillebrand M.E., Baan E., Huismans R., Danner S.A., Ten Veen J.H., De Wolf F.",02699370,"AIDS",13, 1,84,5,4,9,1,94
1999,"Immune-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy","Prins J.M., Roos M.T.L., De Wolf F., Goudsmit J., Schuitemaker H., Lange J.M.A., Jurriaans S., Van Praag R.M.E., Blaak H., Van Rij R., Schellekens P.Th.A., Ten Berge I.J.M., Yong S.-L., Fox C.H.",02699370,"AIDS",13, 17,50,5,2,7,4,61
1999,"Detection of human immunodeficiency virus type 1 nucleocapsid protein p7 in vitro and in vivo","De Baar M.P., Van Der Horn K.H.M., Goudsmit J., De Ronde A., De Wolf F.",00951137,"Journal of Clinical Microbiology",37, 1,1,0,0,0,0,1
1998,"Body mass index course in asymptomatic HIV-infected homosexual men and the predictive value of a decrease of body mass index for progression to AIDS","Maas J.J., Dukers N., Krol A., Van Ameijden E.J.C., Van Leeuwen R., Roos M.Th.L., De Wolf F., Coutinho R.A., Keet I.P.M.",10779450,"Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology",19, 3,7,4,2,6,2,15
1998,"Amsterdam duration of antiretroviral medication (ADAM)--study: induction-suppression treatment in HIV-I infection, preliminary results | Amsterdam duur van antiretrovirale therapie (ADAM)--onderzoek: inductie-onderhoudsbehandeling bij HIV-I-infectie, preliminaire resultaten.","Reijers M.H., ten Kate R.W., de Wolf F., Schuitemaker H., Lange J.M., Weverling G.J., Jurriaans S., Wit F.W., van Leeuwen R., Bruisten S.M., Frissen P.H., Weigel H.M., Mulder J.W.",00282162,"Nederlands tijdschrift voor geneeskunde",142, 40,0,0,0,0,0,0
1998,"Low T-cell responses to CD3 plus CD28 monoclonal antibodies are predictive of development of AIDS","Roos M.Th.L., Prins M., Koot M., De Wolf F., Bakker M., Coutinho R.A., Miedema F., Schellekens P.Th.A.",02699370,"AIDS",12, 14,29,0,3,3,0,32
1998,"Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection","Carotenuto P., Looij D., Keldermans L., De Wolf F., Goudsmit J.",02699370,"AIDS",12, 13,50,9,4,13,4,67
1998,"An open randomized controlled trial of zidovudine plus lamivudine versus stavudine plus lamivudine","Foudraine N.A., De Wolf F., Lange J.M.A., De Jong J.J., Weverling G.J., Van Benthem B.H.B., Maas J., Keet I.P.M., Jurriaans S., Roos M.T.L., Vandermeulen K.",02699370,"AIDS",12, 12,20,1,1,2,0,22
1998,"Rate of HIV-1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen","Notermans D.W., Goudsmit J., Danner S.A., De Wolf F., Perelson A.S., Mittler J.",02699370,"AIDS",12, 12,41,4,3,7,1,49
1998,"Emergence of syncytium-inducing human immunodeficiency virus type 1 variants coincides with a transient increase in viral rna level and is an independent predictor for progression to aids","Spijkerman I., De Wolf F., Langendam M., Schuitemaker H., Coutinho R.",00221899,"Journal of Infectious Diseases",178, 2,17,0,1,1,1,19
1998,"The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapy","Hoetelmans R.M.W., Jurriaans S., Schuitemaker H., De Wolf F., Beijnen J.H., Lange J.M.A., Reijers M.H.E., Weverling G.J., Ten Kate R.W., Wit F.W.N.M., Mulder J.W., Weigel H.M., Jos Frissen P.H., Roos M.",02699370,"AIDS",12, 11,107,2,3,5,0,112
1998,"Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy","Weverling G.J., Danner S.A., Goudsmit J., De Wolf F., Lange J.M.A., Jurriaans S., Prins J.M., Lukashov V.V., Notermans D.W., Roos M., Schuitemaker H., Hoetelmans R.M.W.",02699370,"AIDS",12, 11,70,1,4,5,1,76
1998,"Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam duration of antiretroviral medication (ADAM) study","Reijers M.H.E., Reiss P., Schuitemaker H., De Wolf F., Lange J.M.A., Weverling G.J., Jurriaans S., Wit F.W.N.M., Weigel H.M., Ten Kate R.W., Mulder J.W., Frissen P.H.J., Van Leeuwen R.",01406736,"Lancet",352, 9123,107,4,5,9,3,119
1998,"Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine","Foudraine N.A., Hoetelmans R.M.W., Lange J.M.A., De Wolf F., Van Benthem B.H.B., Maas J.J., Keet I.P.M., Portegies P.",01406736,"Lancet",351, 9115,101,4,1,5,4,110
1998,"Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation","Pakker N.G., Schellekens P.T.A., Notermans D.W., De Boer R.J., Roos M.T.L., De Wolf F., Hill A., Leonard J.M., Danner S.A., Miedema F.",10788956,"Nature Medicine",4, 2,424,18,16,34,12,470
1998,"Virological evaluation of treatment of HIV-infected patients with (combinations of) antiretroviral drugs in the amsterdam academic medical centre, 1996/1997 | Virologische evaluatie van behandeling van HIV-geinfecteerden met (combinaties van) antiretrovirale middelen in het academisch medisch centrum amsterdam, 1996/'97","De Wolf F., De Jong J.J., Hertogs K., Danner S.A., Lange J.M.A., Goudsmit J.",00282162,"Nederlands Tijdschrift voor Geneeskunde",142, 11,2,0,0,0,0,2
1998,"Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine","Notermans D.W., McDade H., Goodwin C., Leonard J.M., Goudsmit J., Danner S.A., Jurriaans S., De Wolf F., Foudraine N.A., De Jong J.J., Cavert W., Schuwirth C.M., Kauffmann R.H., Meenhorst P.L.",02699370,"AIDS",12, 2,62,0,3,3,2,67
1998,"Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy","Foudraine N.A., Lange J.M.A., Reiss P., Weverling G.J., Van Cool T., Roos M.T.L., De Wolf F., Koopmans P.P., Van Den Broek P.J., Meenhorst P.L., Van Leeuwen R.",02699370,"AIDS",12, 1,79,3,3,6,2,87
1997,"AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: Markers with reciprocal predictive value over time after seroconversion","De Wolf F., Goudsmit J., Spijkerman I., Schellekens P.Th., Langendam M., Kuiken C., Bakker M., Roos M., Coutinho R., Miedema F.",02699370,"AIDS",11, 15,72,8,3,11,3,86
1997,"Association between CCR5 genotype and the clinical course of HIV-1 infection","De Roda Husman A.-M., De Wolf F., Coutinho R.A., Miedema F., Goudsmit J., Schuitemaker H., Koot M., Cornelissen M., Keet I.P.M., Brouwer M., Broersen S.M., Bakker M., Roos M.T.L., Prins M.",00034819,"Annals of Internal Medicine",127, 10,122,10,11,21,6,149
1997,"Temporal relationship between human immunodeficiency virus type 1 RNA levels in serum and cellular infectious load in peripheral blood","Blaak H., De Wolf F., Van't Wout A.B., Pakker N.G., Bakker M., Goudsmit J., Schuitemaker H.",00221899,"Journal of Infectious Diseases",176, 5,9,1,2,3,0,12
1997,"Selective inhibition of syncytium-inducing and nonsyncytium-inducing HIV-1 variants in individuals receiving didanosine or zidovudine, respectively","Van 't Wout A.B., Reiss P., Boucher C.A.B., Lange J.M.A., Schuitemaker H., Ran L.J., De Jong M.D., Bakker M., Van Leeuwen R., Notermans D.W., Loeliger A.E., De Wolf F., Danner S.A.",00219738,"Journal of Clinical Investigation",100, 9,18,2,1,3,1,22
1997,"Overshoot of HIV-1 viraemia after early discontinuation of antiretroviral treatment","De Jong M.D., De Boer R.J., De Wolf F., Foudraine N.A., Boucher C.A.B., Goudsmit J., Lange J.M.A.",02699370,"AIDS",11, 11,69,2,0,2,0,71
1997,"Early and late HIV-1 RNA level and its association with other markers and disease progression in long-term AIDS-free homosexual men","Spijkerman I.J.B., Prins M., Goudsmit J., Veugelers P.J., Coutinho R.A., Miedema F., De Wolf F.",02699370,"AIDS",11, 11,28,0,1,1,0,29
1997,"Zidovudine-resistant HIV strains in untreated intravenous drug users and homosexual men infected in 1996 in Amsterdam | Zidovudine-resistente HIV-stammen bij onbehandelde intraveneuze-drugsgebruikers en homoseksuele mannen in Amsterdam, geinfecteerd in 1996","De Jong J.J., Jurriaans S., Coutinho R.A., De Wolf F., Goudsmit J.",00282162,"Nederlands Tijdschrift voor Geneeskunde",141, 42,3,0,0,0,0,3
1997,"Longitudinal analysis of CD4 T cell counts, T cell reactivity, and human immunodeficiency virus type 1 RNA levels in persons remaining AIDS-free despite CD4 cell counts <200 for >5 years","Keet I.P.M., Janssen M., Veugelers P.J., Miedema F., Klein M.R., Goudsmit J., Coutinho R.A., De Wolf F.",00221899,"Journal of Infectious Diseases",176, 3,16,1,1,2,0,18
1997,"High-dose interferon-?2a exerts potent activity against human immunodeficiency virus type I not associated with antitumor activity in subjects with Kaposi's sarcoma","Frissen P.H.J., De Wolf F., Reiss P., Bakker P.J.M., Veenhof C.H.N., Danner S.A., Goudsmit J., Lange J.M.A.",00221899,"Journal of Infectious Diseases",176, 3,10,0,1,1,1,12
1997,"Kinetics of immune functions and virus replication during HIV-1 infection","Pontesilli O., Klein M.R., Kerkhof-Garde S.R., Pakker N.G., De Wolf F., Schuitemaker H., Miedema F.",01652478,"Immunology Letters",57, 1-3,14,0,0,0,0,14
1997,"HIV type 1 subtype C in Addis Ababa, Ethiopia","Abebe A., Rinke De Wit T.F., Kuiken C.L., Goudsmit J., Valk M., Messele T., Sahlu T., Yeneneh H., Fontanet A., De Wolf F.",08892229,"AIDS Research and Human Retroviruses",13, 12,23,2,0,2,0,25
1997,"Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS","Van Baalen C.A., Pontesilli O., Huisman R.C., Geretti A.M., Klein M.R., De Wolf F., Miedema F., Gruters R.A., Osterhaus A.D.M.E.",00221317,"Journal of General Virology",78, 8,120,11,13,24,5,149
1997,"AIDS; new developments. III. Predictive value of the quantity of HIV-RNA for the course of the HIV infection and the effect of the treatment | AIDS; nieuwe ontwikkelingen. III. Voorspellende waarde van de hoeveelheid HIV-RNA voor het beloop van de HIV-infectie en het effect van de behandeling","De Wolf F., Goudsmit J.",00282162,"Nederlands Tijdschrift voor Geneeskunde",141, 21,8,0,0,0,0,8
1996,"A comparison of serum HIV-1 RNA levels as measured by two quantitative assays in zidovudine-treated, asymptomatic, HIV-infected individuals","Weverling G.J., Lange J.M.A., De Jong M.D., De Weerd H., Goudsmit J., De Wolf F.",13596535,"Antiviral Therapy",1, 4,4,0,0,0,0,4
1996,"T cell telomere length in HIV-1 infection: No evidence for increased CD4+ T cell turnover","Wolthers K.C., Meyaard L., Miedema F., Wisman G.B.A., Otto S.A., De Roda Husman A.-M., Schaft N., De Wolf F., Goudsmit J., Coutinho R.A., Van Der Zee A.G.J.",00368075,"Science",274, 5292,172,4,6,10,0,182
1996,"Temporal trends of the natural history of HIV-1 infection following seroconversion between 1984 and 1993 [5]","Keet I.P.M., Veugelers P.J., Koot M., De Weerd M.H., Roos M.Th.L., Miedema F., De Wolf F., Goudsmit J., Coutinho R.A.",02699370,"AIDS",10, 13,9,0,1,1,4,14
1996,"Diverse patterns of recognition of hepatitis C virus core and nonstructural antigens by antibodies present in Egyptian cancer patients and blood donors","Attia M.A.M., Zekri A.-R.N., Goudsmit J., Boom R., Khaled H.M., Mansour M.T., De Wolf F., Alam El-Din H.M., Sol C.J.A.",00951137,"Journal of Clinical Microbiology",34, 11,7,0,1,1,2,10
1996,"Decline of HIV-1 RNA in cerebrospinal fluid during zidovudine treatment.","Portegies P., Danner S.A., Enting R.H., Meilof J., de Wolf F., Goudsmit J.",13596535,"Antiviral therapy",1, 3,1,0,0,0,0,1
1995,"Simultaneous introduction of distinct HIV-1 subtypes into different risk groups in Russia, Byelorussia and Lithuania","Lukashov V.V., Cornelissen M.T.E., Goudsmit J., Papuashvilli M.N., Rytik P.C., Khaitov R.M., Karamov E.V., De Wolf F.",02699370,"AIDS",9, 5,47,1,0,1,1,49
1995,"Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: Low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels","Hogervorst E., Miedema F., Goudsmit J., Jurriaans S., De Wolf F., Van Wijk A., Wiersma A., Valk M., Roos M., Van Gemen B., Coutinho R.",00221899,"Journal of Infectious Diseases",171, 4,106,1,1,2,1,109
1994,"Predictors of disease progression in HIV-infected homosexual men with CD4+ cells < 200 x 106/l but free of AIDS-defining clinical disease","Keet I.P.M., Krol A., Koot M., Roos Th. M.L., De Wolf F., Miedema F., Coutinho R.A.",02699370,"AIDS",8, 11,20,0,0,0,0,20
1994,"HIV-1 infection detected by polymerase chain reaction frequently precedes antibody seroconversion in drug users [6]","Bruisten S.M., Mientjes G.H.C., Van Delft P., De Wolf F., van Ameijden E.J.C., Cornelissen M., Goudsmit J., Coutinho R.A., Huisman J.G.",02699370,"AIDS",8, 12,2,0,0,0,0,2
1994,"Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: Phenotypic and genotypic characteristics","De Wolf F., Sempala S.D.K., Baan E., Zorgdrager F., Lukashov V., Osmanov S., Kuiken C., Cornelissen M., Belsey E.M., Heyward W., Hogervorst E., Goudsmit J., Fenyo E.-M., Rubsamen-Waigmann H., Holmes H., Galvao-Castro B., Karita E., Wasl C.",08892229,"AIDS Research and Human Retroviruses",10, 11,97,6,1,7,1,105
1993,"Antigenic variation of the dominant gp41 epitope in Africa","Lange J.M.A., Goudsmit J., Teeuwsent V.J.P., Boucher C.A.B., Vahlne A., Barin F., Tjong-Hung -A.S., Dekker J., Parkhede U., De Wolf F.",02699370,"AIDS",7, 4,3,0,0,0,0,3
1992,"The 6p21 chromosome region is nonrandomly involved in endometrial polyps","Dal Cin P., De Wolf F., Klerckx P., Van den Berghe H.",00908258,"Gynecologic Oncology",46, 3,8,2,1,3,0,11
1992,"Concordance of human immunodeficiency virus detection by polymerase chain reaction and by serologic assays in a Dutch cohort of seronegative homosexual men","Bruisten S.M., Huisman H.G., Koppelman M.H.G.M., Dekker J.T., Bakker M., De Goede R.E.Y., Roos M.T.L., De Wolf F., Coutinho R.A., Goudsmit J.",00221899,"Journal of Infectious Diseases",166, 3,5,0,0,0,0,5
1992,"Dehydroepiandrosterone as predictor for progression to AIDS in asymptomatic human immunodeficiency virus-infected men","Mulder J.W., Frissen P.H.J., Krijnen P., Endert E., De Wolf F., Goudsmit J., Masterson J.G., Lange J.M.A.",00221899,"Journal of Infectious Diseases",165, 3,39,2,1,3,0,42
1992,"Biphasic rate of CD4+ cell count decline during progression to AIDS correlates with HIV-1 phenotype","Schellekens P.T.A., Tersmette M., Roos M.T.L., Keet R.P., de Wolf F., Coutinho R.A., Miedema F.",02699370,"AIDS",6, 7,55,2,1,3,0,58
1991,"Markers for progression to aids during natural infection and antiviral therapy","Goudsmit J., De Wolf F.",03698114,"Pathologie Biologie",39, 9,0,0,0,0,0,0
1991,"Serologic and immunologic markers in the course of HIV-1 infection","De Wolf F., Lange J.M.A.",0738081X,"Clinics in Dermatology",9, 1,0,0,0,0,0,0
1991,"Characterization of human antibody-binding sites on the external envelope of human immunodeficiency virus type 2","De Wolf F., Meloen R.H., Bakker M., Barin F., Goudsmit J.",00221317,"Journal of General Virology",72, 6,7,0,0,0,0,7
1991,"Antibody reactivity to deletion mutants of the HIV-1 SF2 envelope","Back N.K.T., Haigwood N.L., De Wolf F., De Jongh B.M., Goudsmit J.",03005526,"Intervirology",32, 3,0,0,0,0,0,0
1991,"Phenotypic heterogeneity in a panel of infectious molecular human immunodeficiency virus type 1 clones derived from a single individual","Groenink M., Fouchier R.A.M., De Goede R.E.Y., De Wolf F., Gruters R.A., Cuypers H.T.M., Huisman H.G., Tersmette M.",0022538X,"Journal of Virology",65, 4,43,2,0,2,1,46
1991,"Immune response to HIV p24 core protein during the early phases of human immunodeficiency virus infection","McRae B., Lange J.A.M., Ascher M.S., De Wolf F., Sheppard H.W., Goudsmit J., Allain J.-P.",08892229,"AIDS Research and Human Retroviruses",7, 8,12,0,0,0,0,12
1991,"Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture","Schuitemaker H., Kootstra N.A., De Goede R.E.Y., De Wolf F., Miedema F., Tersmette M.",0022538X,"Journal of Virology",65, 1,148,6,9,15,3,166
1991,"Differences in clinical course in zidovudine-treated asymptomatic HIV-infected men associated with T-cell function at intake","Gruters R.A., Terpstra F.G., Lange J.M.A., Roos M.T., Harkema T., Mulder J.W., De Wolf F., Schellekens a. P.T., Miedema F.",02699370,"AIDS",5, 1,5,0,0,0,0,5
1990,"Long-term zidovudine treatment of asymptomatic HIV-1-infected subjects","Mulder J.W., De Wolf F., Goudsmit J., Cload P.A., Coutinho R.A., Fiddian A.P., Schellekens P.T., Van der Noordaa J., Lange J.M.A.",01663542,"Antiviral Research",13, 3,2,0,0,0,0,2
1990,"Antibody response to viral proteins U (vpu) and R (vpr) in HIV-1-infected individuals","Reiss P., Lange J.M.A., De Ronde A., De Wolf F., Dekker J., Danner S.A., Debouck C., Goudsmit J.",08949255,"Journal of Acquired Immune Deficiency Syndromes",3, 2,5,0,0,0,0,5
1990,"Serum p24 antigen levels in untreated and zidovudine-treated HIV-1 infected subjects","Mulder J.W., Lange J.M.A., De Wolf F., Houweling J.T.M., Bakker M., Coutinho R.A., Goudsmit J.",03002977,"Netherlands Journal of Medicine",37, 1,0,0,0,0,0,0
1990,"Impairment of in vitro immune responses occurs within 3 months after HIV-1 seroconversion","Teeuwsen V.J.P., Siebelink K.H.J., De Wolf F., Goudsmit J., UytdeHaag F.G.C.M., Osterhaus A.D.M.E.",02699370,"AIDS",4, 1,16,2,2,4,1,21
1990,"Risk factors for progression of human immunodeficiency virus (HIV) infection among seroconverted and seropositive homosexual men","Van Griensven G.J.P., De Vroome E.M.M., De Wolf F., Goudsmit J., Roos M., Coutinho R.A.",00029262,"American Journal of Epidemiology",132, 2,18,1,0,1,0,19
1990,"Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam","Van den Hoek J.A.R., Van Haastrecht H.J.A., Goudsmit J., De Wolf F., Coutinho R.A.",00221899,"Journal of Infectious Diseases",162, 4,94,6,4,10,2,106
1990,"Low T-cell responsiveness to activation via CD3/TCR is a prognostic marker for acquired immunodeficiency syndrome (AIDS) in human immunodeficiency Virus-1 (HIV-1)-infected men","Schellekens P.T.A., Roos M.T.L., De Wolf F., Lange J.M.A., Miedema F.",02719142,"Journal of Clinical Immunology",10, 2,49,0,2,2,1,52
1989,"Markers for progression in HIV infection","Lange J.M.A., De Wolf F., Goudsmit J.",02699370,"AIDS",3, 1,27,0,0,0,2,29
1989,"Low antigenicity of HIV-1 rev: rev-specific antibody response of limited value as correlate of rev gene expression and disease progression","Reiss P., De Ronde A., Lange J.M.A., De Wolf F., Dekker J., Danner S.A., Debouck C., Goudsmit J.",08892229,"AIDS Research and Human Retroviruses",5, 6,3,0,0,0,0,3
1989,"Seroconversion to HIV-1 rev- and tat-gene-encoded proteins.","Reiss P., de Ronde A., Dekker J., Aramideh M., de Wolf F., Debouck C., Lange J., Goudsmit J.",02699370,"AIDS",3, 2,2,0,0,0,0,2
1989,"Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality","Tersmette M., Miedema F., De Goede R.E.Y., Eeftink-Schattenkerk J.K.M., Schellekens Th. P.A., Coutinho R.A., Goudsmit J., Lange J.M.A., De Wolf F., Huisman J.G.",01406736,"Lancet",1, 8645,179,6,6,12,5,196
1989,"Antibody response to human immunodeficiency virus type 1 protease according to risk group and disease stage","Boucher C.A.B., De Jager M.H., Debouck C., Epstein L.G., De Wolf F., Wolfs T.F.W., Goudsmit J.",00951137,"Journal of Clinical Microbiology",27, 7,4,0,0,0,0,4
1989,"Antibody response to a synthetic peptide covering a LAV-1/HTLV-IIIB neutralization epitope and disease progression","Boucher C.A.B., De Wolf F., Houweling J.T.M., Bakker M., Dekker J., Roos Th. M.L., Coutinho R.A., Van Der Noordaa J., Goudsmit J.",02699370,"AIDS",3, 2,1,0,0,0,0,1
1989,"Low AIDS attack rate among Dutch haemophiliacs compared to homosexual men: A correlate of HIV antigenaemia frequencies","Wolfs T.F.W., De Wolf F., Breederveld C., Sjamsjoedin-Visser L.J.M., Roos M., Bakker M., Goudsmit J.",00429007,"Vox Sanguinis",57, 2,2,0,0,0,0,2
1989,"Appearance of predictors of disease progression in relation to the development of AIDS","De Wolf F., Lange J.M.A., Houweling J.T.M., Mulder J.W., Beemster J., Schellekens Th. P., Coutinho R.A., Van der Noordaa J., Goudsmit J.",02699370,"AIDS",3, 9,6,0,0,0,0,6
1989,"Longitudinal study of leukocyte functions in homosexual men seroconverted for HIV: rapid and persistent loss of B cell function after HIV infection","Terpstra F.G., Al B.J.M., Roos Th. M.L., De Wolf F., Goudsmit J., Schellekens Th. P.A., Miedema F.",00142980,"European Journal of Immunology",19, 4,36,0,3,3,1,40
1989,"Antibody recognition of amino acid divergence within an HIV-1 neutralization epitope","Goudsmit J., Zwart G., Bakker M., Smit L., Back N., Epstein L., Kuiken C., d'Amaro J., De Wolf F.",09232516,"Research in Virology",140, 5,2,0,0,0,0,2
1989,"Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: Studies on sequential HIV isolates","Tersmette M., Gruters R.A., De Wolf F., De Goede R.E.Y., Lange J.M.A., Schellekens P.T.A., Goudsmit J., Huisman H.G., Miedema F.",0022538X,"Journal of Virology",63, 5,263,13,7,20,10,293
1989,"Effect of human immunodeficiency virus (HIV) antibody knowledge on high-risk sexual behavior with steady and nonsteady sexual partners among homosexual men","Van Griensven G.J.P., De Vroome E.M.M., Tielman R.A.P., Goudsmit J., De Wolf F., Van der Noordaa J., Coutinho R.A.",00029262,"American Journal of Epidemiology",129, 3,16,1,1,2,0,18
1989,"Markers for progression to acquired immune deficiency syndrome and zidovudine treatment of asymptomatic patients","Lange J.M.A., De Wolf F., Mulder J.W., Coutinho R.A., Van der Noordaa J., Goudsmit J.",01634453,"Journal of Infection",18, 1,0,0,0,0,0,0
1989,"Antibodies to an HIV-1 synthetic peptide with partial homology to MULV P15E do not protect against AIDS","Lange J., Vahlne A., Dekker J., De Wolf F., Goudsmit J.",02699370,"AIDS",3, 6,1,0,0,0,0,1
1989,"Cellular and humoral immunity in various cohorts of male homosexuals in relation to infection with human immunodeficiency virus","Roos M.T.L., Miedema F., Eeftinck Schattenkerk J.K.M., De Wolf F., Goudsmit J., Lange J.M.A., Danner S.A., Out T.A., Schellekens P.T.A.",03002977,"Netherlands Journal of Medicine",34, 3-4,4,0,0,0,0,4
1989,"Antibody response to the viral negative factor (nef) in HIV-1 infection: A correlate of levels of HIV-1 expression","Reiss P., De Ronde A., Lange J.M.A., De Wolf F., Dekker J., Debouck C., Goudsmit J.",02699370,"AIDS",3, 4,9,0,0,0,0,9
1988,"Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs","Miedema F., Goudsmit J., Schellekens Th. P.A., Petit A.J.C., Terpstra F.G., Eeftinck Schattenkerk J.K.M., De Wolf F., Al B.J.M., Roos M., Lange J.M.A., Danner S.A.",00219738,"Journal of Clinical Investigation",82, 6,229,6,10,16,3,248
1988,"Decline in CD4+ cell numbers reflects increase in HIV-1 replication","De Wolf F., Roos M., Lange J.M.A., Houweling J.T.M., Coutinho R.A., Van der Noordaa J., Schellekens P.T., Goudsmit J.",08892229,"AIDS Research and Human Retroviruses",4, 6,15,1,0,1,0,16
1988,"Influenza-like syndrome in homosexual men: a prospective diagnostic study.","de Wolf F., Lange J.M., Bakker M., Tjong-A-Hung S., Hooykaas C., Coutinho R., van der Noordaa J., Goudsmit J.",00358797,"Journal of the Royal College of General Practitioners",38, 315,4,0,0,0,0,4
1988,"Impact of HIV antibody testing on changes in sexual behavior among homosexual men in The Netherlands","Van Griensven G.J.P., De Vroome E.M.M., Tielman R.A.P., Goudsmit J., Van Der Noordaa J., De Wolf F., Coutinho R.A.",00900036,"American Journal of Public Health",78, 12,22,0,1,1,1,24
1988,"Effect of zidovudine on human immunodeficiency virus (HIV) antigen in serum of men without symptoms of ARC/AIDS","De Wolf F., Lange J.M.A., Goudsmit J., Cload P., De Gans J., Schellekens P.T.A., Coutinho R.A., Fiddian A.P., Van Der Noordaa J.",00282162,"Nederlands Tijdschrift voor Geneeskunde",132, 28,0,0,0,0,0,0
1988,"Seroconversion to HIV-1 negative regulation factor","De Ronde A., Reiss P., Dekker J., De Wolf F., Van den Hoek A., Wolfs T., Debouck C., Goudsmit J.",01406736,"Lancet",2, 8610,1,0,0,0,0,1
1988,"Decline of HIV antigen levels in cerebrospinal fluid during treatment with low-dose zidovudine","De Gans J., Lange J.M.A., Derix M.M.A., De Wolf F., Eeftinck Schattenkerk J.K.M., Danner S.A., Ongerboer De Visser B.W., Cload P., Goudsmit J.",02699370,"AIDS",2, 1,5,1,0,1,0,6
1988,"Numbers of CD4+ cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men","De Wolf F., Lange J.M.A., Houweling J.T.M., Coutinho R.A., Schellekens P.T., Van der Noordaa J., Goudsmit J.",00221899,"Journal of Infectious Diseases",158, 3,53,1,1,2,1,56
1988,"Serological markers in HIV infection","Lange J.M.A., Goudsmit J., De Wolf F., Coutinho R.A., Van der Noordaa J.",0003410X,"Annales de Medecine Interne",139, 2,0,1,0,1,0,1
1988,"Diagnostic value of specific IgM antibodies in primary HIV infection","Lange J.M.A., Parry J.V., De Wolf F., Mortimer P.P., Goudsmit J.",02699370,"AIDS",2, 1,11,2,0,2,0,13
1988,"No predictive value of GC phenotypes for HIV infection and progression to AIDS","Pronk J.C., Frants R.R., Crusius B., Eriksson A.W., De Wolf F., Boucher C.A.B., Bakker M., Goudsmit J.",03406717,"Human Genetics",80, 2,1,0,0,0,0,1
1988,"Effects of zidovudine on serum human immunodeficiency virus antigen levels in symptom-free subjects","De Wolf F., Lange J.M.A., Goudsmit J., Cload P., De Gans J., Schellekens Th. P.A., Coutinho R.A., Fiddian A.P., Van der Noordaa J.",01406736,"Lancet",1, 8582,5,0,0,0,0,5
1988,"Decrease of HIV antigen levels in cerebrospinal fluid during treatment with zidovudine in AIDS patients","De Gans J., Lange J.M.A., Derix M.M.A., De Wolf F., Ongerboer de Visser B.W., Goudsmit J.",00282162,"Nederlands Tijdschrift voor Geneeskunde",132, 36,0,0,0,0,0,0
1987,"Decline of antibody reactivity to outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 decline","Lange J.M.A., De Wolf F., Krone W.J.A., Danner S.A., Coutinho R.A., Goudsmit J.",02699370,"AIDS",1, 3,14,1,0,1,0,15
1987,"Viral gene expression, antibody production and immune complex formation in human immunodeficiency virus infection","Lange J.M.A., Paul D.A., De Wolf F., Coutinho R.A., Goudsmit J.",02699370,"AIDS",1, 1,7,0,0,0,1,8
1987,"Authors' reply","Khong T.Y., Robertson W.B., Brosens I., De Wolf F.",03065456,"British Journal of Obstetrics and Gynaecology",94, 11,0,0,0,0,0,0
1987,"Spread of human T-cell leukemia virus (HTLV-I) in the Dutch homosexual community.","Goudsmit J., de Wolf F., van de Wiel B., Smit L., Bakker M., Albrecht-van Lent N., Coutinho R.A.",01466615,"Journal of Medical Virology",23, 2,1,0,0,0,0,1
1987,"Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia","De Wolf F., Goudsmit J., Paul D.A.",09598146,"British Medical Journal",295, 6598,29,0,1,1,1,31
1986,"LAV/HTLV-III infection among homosexual males; prevalence, incidence and possible cofactors","De Wolf F., Coutinho R.A., Goudsmit J.",00282162,"Nederlands Tijdschrift voor Geneeskunde",130, 48,0,0,0,0,0,0
1986,"Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection","Goudsmit J., De Wolf F., Paul D.A.",01406736,"Lancet",2, 8500,67,3,2,5,1,73
1986,"Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants","Khong T.Y., De Wolf F., Robertson W.B., Brosens I.",03065456,"British Journal of Obstetrics and Gynaecology",93, 10,476,49,42,91,33,600
1984,"The making of the placental bed","Robertson W.B., Brosens I., Pijnenborg R., De Wolf F.",03012115,"European Journal of Obstetrics Gynecology and Reproductive Biology",18, 5-6,4,2,1,3,0,7
1984,"Antenatal ultrasound diagnosis of fetal malformations: Possibilities, limitations and dilemmas","Vandenberghe K., De Wolf F., Fryns J.P.",03012115,"European Journal of Obstetrics Gynecology and Reproductive Biology",18, 5-6,4,0,0,0,0,4
1982,"Ultrastructure of uteroplacental arteries","De Wolf F., Brosens I., Robertson W.B.",03044246,"Contributions to Gynecology and Obstetrics",9, ,11,2,0,2,1,14
1982,"Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant","De Wolf F., Carreras L.O., Moerman P.",00029378,"American Journal of Obstetrics and Gynecology",142, 7,121,8,4,12,5,138
1980,"The human placental bed: Electron microscopic study of trophoblastic invasion of spiral arteries","De Wolf F., De Wolf-Peeters C., Brosens I., Robertson W.B.",00029378,"American Journal of Obstetrics and Gynecology",137, 1,41,1,1,2,1,44
1980,"Fetal growth retardation and the maternal arterial supply of the human placenta in the absence of sustained hypertension","De Wolf F., Brosens I., Renaer M.",03065456,"British Journal of Obstetrics and Gynaecology",87, 8,47,7,4,11,2,60
1975,"The ultrastructure of acute atherosis in hypertensive pregnancy","De Wolf F., Robertson W.B., Brosens I.",00029378,"American Journal of Obstetrics and Gynecology",123, 2,53,3,3,6,1,60
1973,"Ultrastructure of the spiral arteries in the human placental bed at the end of normal pregnancy","De Wolf F., De Wolf Peeters C., Brosens I.",00029378,"American Journal of Obstetrics and Gynecology",117, 6,41,2,0,2,0,43
